About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 755 record(s)
Req # A-2022-000426
All receipts for the expense referred to in Sessional Paper 8555-441-494, tabled in the House of Commons on June 8, 2022, with the following vendor, amount, date of expenditure, and file number: Clear Sky Vapes, $37.00, March 24th, 2022, 162857.Organization: Health Canada
March 2023
Req # A-2022-000690
The following submissions:GLUMETZA , GLUMETZA (SB) - METFORMIN HYDROCHLORIDE. BAUSCH HEALTH, CANADA INC. Notice of Compliance (NOC) Date: 2022/01/25. Supplements to New Drug Submission (SNDS). Reason for Update: Update the design of bottle labels…Organization: Health Canada
March 2023
Req # A-2022-000802
Clinical and chemistry review report for PEMETREXED FOR INJECTION 25 MG / ML from Accord Healthcare Inc. on 2021-04-29 by Health Canada.Organization: Health Canada
March 2023
Req # A-2022-000916
The Imperial Tobacco Canada Ltd. submission in response to consultation on the proposed Regulations Amending the Tobacco Products Regulations published in the Canada Gazette Part I on June 11, 2022.Organization: Health Canada
March 2023
Req # A-2022-000992
The initial cover letter or any other document indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-10-20 for the medicinal…Organization: Health Canada
March 2023
Req # A-2022-001068
All internal or external evaluations about the effectiveness, efficiency, and equity of work performed by teleworkers and hybrid workers from the period of March 1, 2020 to November 1, 2022. Any manuals, guidelines, written policies, procedures and…Organization: Health Canada
March 2023
Req # A-2022-001195
All correspondence between Health Canada Office of Pharmaceutical Management Strategies and the Patented Medicine Prices Review Board pertaining to the October 2022 revised draft Guidelines.Organization: Health Canada
March 2023
Req # A-2022-001307
Seizure data, sourced from Seizure and Disposition reports, on illicit opioids broken down by number of seizures, volume, year, and province. Volumes of illicit fentanyl and derivatives seized broken down by province and year. Any data relating to…Organization: Health Canada
March 2023
Req # A-2022-001382
All documents listing the modalities of the Public Service Occupational Health Program (PSOHP) regarding correctional officers from the Correctional Service of Canada. The documents detailing the services offered by the Program, the conditions or…Organization: Health Canada
March 2023
Req # A-2022-001408
Meeting between Health Canada and the Patented Medicines Prices Review Board (PMPRB), in November-December 2022. The following records: A list of attendees for the meeting. A copy of the calendar invitation for the meeting, including any…Organization: Health Canada
March 2023